-
| Industry | Medical Devices |
|---|---|
| Sector | Healthcare |
| ISIN | US6412881053 |
| CurrencyCode | USD |
| Exchange | NASDAQ |
| Beta | nan |
|---|---|
| Target Price | 6.9 |
| Dividend Yield | 0.0% |
| PE Ratio | None |
| Market Cap | 119M |
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NPCE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024